As diabetes care continues to be a major focus, promising treatments are emerging . Retatrutide, Tirzepatide, and Semaglutide represent a noteworthy generation in incretin mimetic medications. While all aim to https://bookmarkfly.com/story22141729/the-new-drug-vs-tirzepatid-vs-semaglutide-a-direct-look